image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 26.66
-2.33 %
$ 1.31 B
Market Cap
60.59
P/E
1. INTRINSIC VALUE

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.[ Read More ]

The intrinsic value of one STAA stock under the base case scenario is HIDDEN Compared to the current market price of 26.7 USD, STAAR Surgical Company is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart STAA

image
FINANCIALS
322 M REVENUE
13.37%
28.1 M OPERATING INCOME
-35.85%
21.3 M NET INCOME
-45.27%
14.6 M OPERATING CASH FLOW
-59.14%
74.3 M INVESTING CASH FLOW
147.54%
7.42 M FINANCING CASH FLOW
-10.63%
88.6 M REVENUE
-10.52%
5.68 M OPERATING INCOME
-52.24%
9.98 M NET INCOME
35.25%
3.82 M OPERATING CASH FLOW
136.65%
-35.2 M INVESTING CASH FLOW
-70.51%
1.62 M FINANCING CASH FLOW
890.80%
Balance Sheet Decomposition STAAR Surgical Company
image
Current Assets 365 M
Cash & Short-Term Investments 221 M
Receivables 98 M
Other Current Assets 46.6 M
Non-Current Assets 123 M
Long-Term Investments 11.7 M
PP&E 101 M
Other Non-Current Assets 10.3 M
Current Liabilities 65 M
Accounts Payable 13.6 M
Short-Term Debt 8.73 M
Other Current Liabilities 42.7 M
Non-Current Liabilities 37.7 M
Long-Term Debt 31.5 M
Other Non-Current Liabilities 6.24 M
EFFICIENCY
Earnings Waterfall STAAR Surgical Company
image
Revenue 322 M
Cost Of Revenue 69.8 M
Gross Profit 253 M
Operating Expenses 225 M
Operating Income 28.1 M
Other Expenses 6.75 M
Net Income 21.3 M
RATIOS
78.36% GROSS MARGIN
78.36%
8.71% OPERATING MARGIN
8.71%
6.62% NET MARGIN
6.62%
5.53% ROE
5.53%
4.37% ROA
4.37%
4.56% ROIC
4.56%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis STAAR Surgical Company
image
Net Income 21.3 M
Depreciation & Amortization 5.12 M
Capital Expenditures -18.2 M
Stock-Based Compensation 23.5 M
Change in Working Capital -40.8 M
Others -38 M
Free Cash Flow -3.59 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets STAAR Surgical Company
image
Wall Street analysts predict an average 1-year price target for STAA of $49.3 , with forecasts ranging from a low of $45 to a high of $60 .
STAA Lowest Price Target Wall Street Target
45 USD 68.90%
STAA Average Price Target Wall Street Target
49.3 USD 84.76%
STAA Highest Price Target Wall Street Target
60 USD 125.06%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership STAAR Surgical Company
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
50 K USD 1
3-6 MONTHS
66.7 K USD 2
6-9 MONTHS
20.3 M USD 2
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Aug 12, 2024
Bought 50 K USD
Butcher Arthur C
Director
+ 1315
37.99 USD
6 months ago
May 09, 2024
Bought 42.6 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 1
42.56 USD
6 months ago
May 09, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
8 months ago
Mar 14, 2024
Bought 66.7 K USD
WEISNER AIMEE S
Director
+ 1750
38.11 USD
10 months ago
Jan 08, 2024
Bought 110 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 4042
27.1079 USD
10 months ago
Jan 08, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
10 months ago
Jan 05, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
10 months ago
Jan 05, 2024
Bought 2.89 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 100
28.895 USD
10 months ago
Jan 05, 2024
Bought 4.46 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 156634
28.4762 USD
10 months ago
Jan 05, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
10 months ago
Jan 04, 2024
Bought 1.83 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 63246
28.9059 USD
10 months ago
Jan 04, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
10 months ago
Jan 03, 2024
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
10 months ago
Jan 03, 2024
Bought 190 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 6573
28.928 USD
11 months ago
Dec 06, 2023
Bought 26.1 K USD
Zhou Lilian Yansheng
Director
+ 850
30.74 USD
11 months ago
Nov 30, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
11 months ago
Nov 30, 2023
Bought 5.58 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 177707
31.4207 USD
11 months ago
Nov 29, 2023
Bought 90.4 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 2827
31.9908 USD
11 months ago
Nov 29, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
11 months ago
Nov 29, 2023
Bought 4.94 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 157473
31.3763 USD
11 months ago
Nov 29, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
11 months ago
Nov 28, 2023
Bought 161 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 5040
32.0034 USD
11 months ago
Nov 28, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
11 months ago
Nov 28, 2023
Bought 2.93 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 91944
31.84 USD
11 months ago
Nov 28, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 13, 2023
Bought 16.7 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 507
33.0362 USD
1 year ago
Nov 13, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 10, 2023
Bought 1.12 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 34320
32.7326 USD
1 year ago
Nov 10, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 09, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 09, 2023
Bought 693 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 20610
33.6394 USD
1 year ago
Nov 09, 2023
Bought 3.94 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 119390
32.995 USD
1 year ago
Nov 09, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 08, 2023
Bought 4.7 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 139409
33.7071 USD
1 year ago
Nov 08, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 07, 2023
Bought 331 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 9731
34.0281 USD
1 year ago
Nov 07, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 06, 2023
Bought 5.62 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 164607
34.1633 USD
1 year ago
Nov 06, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 03, 2023
Bought 18.8 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 520
36.0626 USD
1 year ago
Nov 03, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 02, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 02, 2023
Bought 2.02 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 56178
36.0322 USD
1 year ago
Nov 02, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Nov 02, 2023
Bought 3.13 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 87849
35.641 USD
1 year ago
Oct 06, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Oct 06, 2023
Bought 2.83 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 75299
37.6156 USD
1 year ago
Oct 05, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Oct 05, 2023
Bought 3.7 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 97474
37.9219 USD
1 year ago
Oct 04, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Oct 04, 2023
Bought 1.23 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 32523
37.9316 USD
1 year ago
Sep 21, 2023
Bought 100 K USD
Lin Elizabeth Yeu
Director
+ 2500
40 USD
1 year ago
Sep 21, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Sep 21, 2023
Bought 6.13 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 154814
39.6183 USD
1 year ago
Sep 20, 2023
Bought 5.37 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 132079
40.6747 USD
1 year ago
Sep 20, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Sep 19, 2023
Bought 184 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 4490
40.8937 USD
1 year ago
Sep 19, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Sep 07, 2023
Bought 2.51 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 60874
41.261 USD
1 year ago
Sep 07, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Sep 06, 2023
Bought 4.51 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 108944
41.4317 USD
1 year ago
Sep 06, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Sep 05, 2023
Bought 843 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 20144
41.8713 USD
1 year ago
Sep 05, 2023
Bought 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
+ 0
0 USD
1 year ago
Aug 07, 2023
Bought 97.4 K USD
WEISNER AIMEE S
Director
+ 2000
48.72 USD
1 year ago
Mar 17, 2023
Sell 51 K USD
Holliday Keith
Chief Technology Officer
- 823
61.97 USD
1 year ago
Dec 29, 2022
Bought 0 USD
BROADWOOD PARTNERS, L.P.
Director
+ 0
0 USD
1 year ago
Dec 28, 2022
Bought 0 USD
BROADWOOD PARTNERS, L.P.
Director
+ 0
0 USD
1 year ago
Dec 27, 2022
Bought 0 USD
BROADWOOD PARTNERS, L.P.
Director
+ 0
0 USD
2 years ago
Sep 27, 2022
Sell 500 K USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 6667
75 USD
2 years ago
Sep 27, 2022
Sell 981 K USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 13075
75 USD
2 years ago
Aug 15, 2022
Sell 1.23 M USD
Holliday Keith
Chief Technology Officer
- 11582
106.32 USD
2 years ago
May 20, 2022
Sell 2.05 M USD
Mason Caren L
President & CEO
- 35000
58.48 USD
2 years ago
May 18, 2022
Sell 2.01 M USD
Mason Caren L
President & CEO
- 35000
57.49 USD
2 years ago
May 18, 2022
Sell 1.98 M USD
Mason Caren L
President & CEO
- 35000
56.46 USD
2 years ago
Mar 21, 2022
Sell 68.8 K USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 922
74.62 USD
2 years ago
Mar 14, 2022
Sell 18.5 K USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 289
64.18 USD
2 years ago
Dec 14, 2021
Sell 537 K USD
Holliday Keith
Chief Technology Officer
- 6000
89.57 USD
3 years ago
Nov 18, 2021
Sell 3.98 M USD
Mason Caren L
President & CEO
- 35000
113.83 USD
3 years ago
Nov 16, 2021
Sell 4 M USD
Mason Caren L
President & CEO
- 35000
114.2 USD
3 years ago
Oct 04, 2021
Sell 1.72 M USD
Gesten Samuel J
Chief Legal Officer
- 15000
114.53 USD
3 years ago
Sep 16, 2021
Sell 714 K USD
Williams Patrick F.
Chief Financial Officer
- 5121
139.38 USD
3 years ago
Sep 07, 2021
Sell 4.59 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 29131
157.4 USD
3 years ago
Sep 01, 2021
Sell 2.77 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 17573
157.61 USD
3 years ago
Sep 02, 2021
Sell 2.73 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 17343
157.5 USD
3 years ago
Aug 18, 2021
Sell 2.2 M USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 15000
146.91 USD
3 years ago
Aug 12, 2021
Sell 4 M USD
Gesten Samuel J
Chief Legal Officer
- 29682
134.71 USD
3 years ago
Aug 11, 2021
Sell 351 K USD
Williams Patrick F.
Chief Financial Officer
- 2500
140.58 USD
3 years ago
Aug 10, 2021
Sell 1.46 M USD
SILVERMAN LOU
Director
- 10000
145.57 USD
3 years ago
Aug 10, 2021
Sell 1.46 M USD
SILVERMAN LOU
Director
- 10000
145.56 USD
3 years ago
Aug 10, 2021
Sell 1.44 M USD
SILVERMAN LOU
Director
- 9921
145.54 USD
3 years ago
Jun 24, 2021
Sell 10.7 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 67708
157.83 USD
3 years ago
Jun 24, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 25, 2021
Sell 4.79 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 30735
155.84 USD
3 years ago
Jun 25, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 28, 2021
Sell 20.2 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 130000
155.19 USD
3 years ago
Jun 28, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 16, 2021
Sell 4.54 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 30543
148.79 USD
3 years ago
Jun 16, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 17, 2021
Sell 9.6 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 63896
150.31 USD
3 years ago
Jun 17, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 18, 2021
Sell 2.02 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 13236
152.59 USD
3 years ago
Jun 18, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 11, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 11, 2021
Sell 335 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 2275
147.05 USD
3 years ago
Jun 14, 2021
Sell 3.24 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 21895
147.79 USD
3 years ago
Jun 14, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jun 15, 2021
Sell 5.22 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 35380
147.46 USD
3 years ago
Jun 15, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
May 27, 2021
Sell 6.82 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 47571
143.42 USD
3 years ago
May 27, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
Director
- 0
0 USD
3 years ago
May 28, 2021
Sell 32.1 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 217693
147.43 USD
3 years ago
May 28, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
Director
- 0
0 USD
3 years ago
Jun 01, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
Director
- 0
0 USD
3 years ago
Jun 01, 2021
Sell 148 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 1014
146.36 USD
3 years ago
May 21, 2021
Sell 1.94 M USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 15261
126.83 USD
3 years ago
May 24, 2021
Sell 1.89 M USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 14500
130.42 USD
3 years ago
May 24, 2021
Sell 12.4 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 94855
130.42 USD
3 years ago
May 21, 2021
Sell 659 K USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 5145
128 USD
3 years ago
May 11, 2021
Sell 5.92 M USD
Mason Caren L
President & CEO
- 53500
110.7 USD
3 years ago
May 10, 2021
Sell 6.41 M USD
Mason Caren L
President & CEO
- 53500
119.88 USD
3 years ago
May 10, 2021
Sell 1.12 M USD
Holliday Keith
Chief Technology Officer
- 8874
125.83 USD
3 years ago
May 10, 2021
Sell 1.34 M USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 10760
124.13 USD
3 years ago
May 10, 2021
Sell 169 K USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 1349
125.22 USD
3 years ago
May 11, 2021
Sell 1.24 M USD
Hansen Graydon C.
Sr. VP, Global Operations
- 11075
111.61 USD
3 years ago
May 12, 2021
Sell 613 K USD
Hansen Graydon C.
Sr. VP, Global Operations
- 5531
110.74 USD
3 years ago
May 10, 2021
Sell 1.46 M USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 11583
125.72 USD
3 years ago
Apr 22, 2021
Sell 2.69 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 20669
130.34 USD
3 years ago
Apr 22, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Apr 23, 2021
Sell 7.19 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 53854
133.51 USD
3 years ago
Apr 23, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Apr 26, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Apr 26, 2021
Sell 5.87 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 43383
135.3 USD
3 years ago
Mar 22, 2021
Sell 106 K USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 1103
96.37 USD
3 years ago
Mar 22, 2021
Sell 99.5 K USD
Gesten Samuel J
Chief Legal Officer
- 1032
96.37 USD
3 years ago
Mar 22, 2021
Sell 88.9 K USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 922
96.37 USD
3 years ago
Mar 01, 2021
Sell 2.51 M USD
SILVERMAN LOU
Director
- 23996
104.78 USD
3 years ago
Mar 02, 2021
Sell 4.66 M USD
Mason Caren L
President & CEO
- 45000
103.53 USD
3 years ago
Mar 01, 2021
Sell 4.71 M USD
Mason Caren L
President & CEO
- 45000
104.76 USD
3 years ago
Mar 03, 2021
Sell 4.42 M USD
Mason Caren L
President & CEO
- 45000
98.32 USD
3 years ago
Mar 01, 2021
Sell 541 K USD
Holliday Keith
Chief Technology Officer
- 5208
103.85 USD
3 years ago
Mar 01, 2021
Sell 1.44 M USD
Holliday Keith
Chief Technology Officer
- 13783
104.82 USD
3 years ago
Mar 01, 2021
Sell 1.69 M USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 16000
105.43 USD
3 years ago
Mar 01, 2021
Sell 2.09 M USD
Hansen Graydon C.
Sr. VP, Global Operations
- 20294
103.21 USD
3 years ago
Mar 01, 2021
Sell 219 K USD
Hansen Graydon C.
Sr. VP, Global Operations
- 2069
106.03 USD
3 years ago
Mar 01, 2021
Sell 1.18 M USD
Hansen Graydon C.
Sr. VP, Global Operations
- 11427
103.05 USD
3 years ago
Feb 10, 2021
Sell 973 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 7789
124.9 USD
3 years ago
Feb 10, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 11, 2021
Sell 923 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 7412
124.51 USD
3 years ago
Feb 11, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 12, 2021
Sell 2.76 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 22250
124.22 USD
3 years ago
Feb 12, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 05, 2021
Sell 5.54 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 47700
116.09 USD
3 years ago
Feb 05, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 08, 2021
Sell 17.7 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 144838
122.28 USD
3 years ago
Feb 08, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 09, 2021
Sell 8.08 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 65081
124.09 USD
3 years ago
Feb 09, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 02, 2021
Sell 175 K USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 1589
110.32 USD
3 years ago
Feb 02, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 03, 2021
Sell 1.17 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 10585
110.44 USD
3 years ago
Feb 03, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Feb 04, 2021
Sell 5.41 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 48687
111.15 USD
3 years ago
Feb 04, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jan 26, 2021
Sell 35.5 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 347000
102.33 USD
3 years ago
Jan 26, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jan 27, 2021
Sell 17.1 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 164686
103.99 USD
3 years ago
Jan 27, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jan 28, 2021
Sell 29.4 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 278197
105.83 USD
3 years ago
Jan 28, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Jan 12, 2021
Sell 5.36 M USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 60000
89.28 USD
3 years ago
Jan 12, 2021
Sell 0 USD
BROADWOOD PARTNERS, L.P.
10 percent owner
- 0
0 USD
3 years ago
Nov 23, 2020
Sell 1.52 M USD
Francese James E
Sr. VP, Comm. Ops., NA, APAC
- 18959
80.13 USD
3 years ago
Nov 19, 2020
Sell 1.15 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 14007
82.03 USD
3 years ago
Nov 23, 2020
Sell 158 K USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 1900
83.02 USD
3 years ago
Nov 23, 2020
Sell 239 K USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 2874
83.14 USD
4 years ago
Nov 09, 2020
Sell 1.63 M USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 20000
81.34 USD
4 years ago
Nov 09, 2020
Sell 1.93 M USD
Holliday Keith
Chief Technology Officer
- 23714
81.56 USD
4 years ago
Sep 14, 2020
Sell 1.42 M USD
Holliday Keith
Chief Technology Officer
- 26574
53.26 USD
4 years ago
Sep 15, 2020
Sell 1.94 M USD
Holliday Keith
Chief Technology Officer
- 36326
53.33 USD
4 years ago
Sep 14, 2020
Sell 488 K USD
Holliday Keith
Chief Technology Officer
- 9115
53.49 USD
4 years ago
Sep 09, 2020
Sell 7.15 M USD
Moore John C
Director
- 137331
52.04 USD
4 years ago
Aug 10, 2020
Sell 2.13 M USD
Hayashida Jon K.
VP, Global Clinical, Medical
- 41602
51.22 USD
4 years ago
Jun 15, 2020
Sell 1.73 M USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 39215
44.07 USD
4 years ago
Jun 10, 2020
Sell 34.5 K USD
Blickensdoerfer Hans-Martin
Sr. VP, Comm. Ops, China
- 785
44 USD
4 years ago
May 21, 2020
Sell 7.7 M USD
Gesten Samuel J
Chief Legal Officer
- 192522
40 USD
4 years ago
May 15, 2020
Sell 942 K USD
Holliday Keith
Chief Technology Officer
- 25000
37.69 USD
7. News
A Dive into Staar Surgical (STAA) International Revenue Trends and Forecasts Evaluate Staar Surgical's (STAA) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance. zacks.com - 1 week ago
STAAR Surgical Company (STAA) Q3 2024 Earnings Call Transcript STAAR Surgical Company (NASDAQ:STAA ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Brian Moore - VP, IR Tom Frinzi - Chair, President and CEO Patrick Williams - CFO Conference Call Participants Tom Stephan - Stifel Ryan Zimmerman - BTIG Patrick Wood - Morgan Stanley Operator Greetings and welcome to the STAAR Surgical Third Quarter 2024 Earnings Webcast. As a reminder, this event is being recorded today Wednesday, October 30th, 2024. seekingalpha.com - 2 weeks ago
CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results LAKE FOREST, Calif.--(BUSINESS WIRE)--The end of the paragraph after bullets in the "Outlook" section of release should read: APAC sales growth of 5% (prior outlook was 7%), including approximately 2% growth in China (prior outlook was 10%) and all other APAC countries approximately 10-20% growth (prior outlook was flat). (Instead of: APAC sales growth of 4% (prior outlook was 7%), including approximately 2% growth in China (prior outlook was 10%). The updated release reads:  STAAR SURGICAL REP. businesswire.com - 2 weeks ago
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates Staar Surgical (STAA) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.30 per share a year ago. zacks.com - 2 weeks ago
STAAR Surgical Reports Third Quarter 2024 Results LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today reported financial results for the third quarter ended September 27, 2024. Third Quarter 2024 Overview Net sales of $88.6 million, up 10% from prior year quarter ICL sales of $89.1 million, up 10% from prior year quarter Gross margin of 77.3% as compared to 79.2% year. businesswire.com - 2 weeks ago
STAAR Surgical to Report Third Quarter Results on October 30, 2024 LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that it will release financial results for the third quarter ended September 27, 2024, on Wednesday, October 30, 2024, after the market close. Event: STAAR Surgical 3Q 2024 Financial Results Webcast Date: Wednesday, October 30, 2024 Time: 4:30 p.m. ET / 1:30. businesswire.com - 3 weeks ago
Here's Why Staar Surgical (STAA) Could be Great Choice for a Bottom Fisher Staar Surgical (STAA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term. zacks.com - 1 month ago
Fast Money traders share their favorite stocks of the week Fast Money traders Steve Grasso, Tim Seymour, Julie Biel, and Mike Khouw share their favorite stocks from this week and explain the reasoning behind their choices. youtube.com - 1 month ago
Wall Street Analysts Predict a 43.93% Upside in Staar Surgical (STAA): Here's What You Should Know The mean of analysts' price targets for Staar Surgical (STAA) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 1 month ago
4 Stocks to Buy Amid Dental Supplies Industry Challenges Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA. zacks.com - 1 month ago
Staar Surgical (STAA) Moves to Buy: Rationale Behind the Upgrade Staar Surgical (STAA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 2 months ago
STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize STAAR Surgical shares are down more than 15% since Q2 earnings, despite management raising full-year revenue guidance. Investments in the US market appear to be yielding promising results, as sales were up 25% year over year. According to my estimates, the company is on track to meet the low end of its 2026 financial targets. seekingalpha.com - 2 months ago
8. Profile Summary

STAAR Surgical Company STAA

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 1.31 B
Dividend Yield 0.00%
Description STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Contact 25651 Atlantic Ocean Drive, Lake Forest, CA, 92630 https://www.staar.com
IPO Date Feb. 24, 1992
Employees 1056
Officers Dr. Scott D. Barnes M.D. Chief Medical Officer Mr. Patrick F. Williams Chief Financial Officer Mr. Thomas G. Frinzi President, Chief Executive Officer & Chairman Mr. Brian Moore Vice President of Investor Relations & Corporate Development Ms. Nancy Sabin Chief Marketing Officer Mr. James Francese Senior Vice President of Commercial Operations - North America & APAC Dr. Magda Michna Ph.D. Chief Clinical, Regulatory & Medical Affairs Officer Dr. Keith Holliday Ph.D. Chief Technology Officer Mr. Warren Foust Chief Operating Officer Mr. Nathaniel B. Sisitsky Esq. General Counsel & Corporate Secretary